Mode
Text Size
Log in / Sign up

Longitudinal TCR profiling predicts EBV, CMV, and GVHD in 108 allo-HSCT recipients

Longitudinal TCR profiling predicts EBV, CMV, and GVHD in 108 allo-HSCT recipients
Photo by CDC / Unsplash
Key Takeaway
Consider TCR repertoire monitoring for early risk stratification in allo-HSCT recipients.

This longitudinal cohort study examined TCR beta repertoire profiling in 108 allogeneic hematopoietic stem cell transplantation recipients and their corresponding donors. The investigation focused on early post-transplant time points to assess immune perturbations associated with graft-versus-host disease, Epstein-Barr virus reactivation, and cytomegalovirus reactivation. The authors utilized fusion models to predict these outcomes based on repertoire metrics.

The analysis revealed that reduced baseline TCR diversity was most strongly associated with Epstein-Barr virus reactivation. Cytomegalovirus reactivation was linked to post-transplant repertoire remodeling characterized by clonal expansion and reduced donor-recipient repertoire similarity. Fusion models achieved area under the curve values of 0.745 for cytomegalovirus reactivation prediction, 0.819 for Epstein-Barr virus reactivation prediction, and 0.834 for graft-versus-host disease prediction.

The authors note that whether immune perturbations precede these events remains unclear. Safety data, adverse events, and discontinuations were not reported. The study supports the potential utility of TCR repertoire monitoring for early risk stratification after transplantation, but caution is warranted regarding causality and clinical utility.

Study Details

EvidenceLevel 5
PublishedApr 2026
View Original Abstract ↓
Early complications following allogeneic hematopoietic stem cell transplantation (allo-HSCT), including graft-versus-host disease (GVHD) and viral reactivation, remain major causes of post-transplant morbidity, but whether immune perturbations precede these events remains unclear. We performed longitudinal TCR beta repertoire profiling in 108 allo-HSCT recipients and their corresponding donors at baseline and three early post-transplant time points to characterize immune reconstitution dynamics. Reduced baseline TCR diversity was most strongly associated with subsequent Epstein-Barr virus (EBV) reactivation, whereas cytomegalovirus (CMV) reactivation was more closely linked to post-transplant repertoire remodeling characterized by clonal expansion and reduced donor-recipient repertoire similarity. Sequence-based predictive modeling demonstrated meaningful discrimination, with fusion models achieving area under the curve (AUC) values of 0.745 for CMV, 0.819 for EBV, and 0.834 for GVHD. Temporal analyses further revealed complication-specific predictive windows. These findings indicate that major post-transplant complications are preceded by detectable immune perturbations and support the potential utility of TCR repertoire monitoring for early risk stratification after transplantation.
Free Newsletter

Clinical research that matters. Delivered to your inbox.

Join thousands of clinicians and researchers. No spam, unsubscribe anytime.